Background: Ménière's disease (MD) is defined as an idiopathic disorder of the inner ear characterized by the triad of tinnitus, vertigo, and sensorineural hearing loss. Although many studies have evaluated the association between variants in the KCNE1 or KCNE3 gene and MD risk, debates still exist.
Objective: Our aim is to evaluate the association between KCNE gene variants, including KCNE1 rs1805127 and KCNE3 rs2270676, and the risk of MD by a systematic review.
Methods: We searched the literature in PubMed, SCOPUS and EMBASE through May 2015. We calculated pooled odds ratios (OR) and 95% confidence intervals (CIs) using a fixed-effects model or a random-effects model for the risk to MD associated with different KCNE gene variants. The heterogeneity assumption decided the effect model.
Results: A total of three relevant studies, with 302 MD cases and 515 controls, were included in this meta-analysis. The results indicated that neither the KCNE1 rs1805127 variant (for G vs. A: OR = 0.724, 95%CI 0.320, 1.638, P= 0.438), nor the KCNE3 rs2270676 variant (for T vs. C: OR = 0.714, 95%CI 0.327, 1.559, P = 0.398) was associated with MD risk.
Conclusions: Based on current evidence from published studies, neither of the two variants from KCNE was significantly associated with the risk of MD. Larger studies with mixed ethnicity subjects and stratified by clinical and sub-clinical characteristics are needed to validate our findings.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3233/VES-160569 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Congenital Hyperinsulinism and Long QT Syndrome Attributable to a Variant in KCNE1.
Horm Res Paediatr
January 2025
Division of Endocrinology and Diabetes, Congenital Hyperinsulinism Center, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Introduction: This is a report of a child with congenital hyperinsulinism associated with a loss-of-function variant in KCNE1. KCNE1 encodes a human potassium channel accessory (beta) subunit that modulates potassium channel Kv7.1 (encoded by KCNQ1).
View Article and Find Full Text PDFA Titin Missense Variant Causes Atrial Fibrillation.
medRxiv
December 2024
Division of Cardiology, Department of Medicine, University of Illinois Chicago, Chicago, IL, USA.
Rare and common genetic variants contribute to the risk of atrial fibrillation (AF). Although ion channels were among the first AF candidate genes identified, rare loss-of-function variants in structural genes such as have also been implicated in AF pathogenesis partly by the development of an atrial myopathy, but the underlying mechanisms are poorly understood. While truncating variants (tvs) have been causally linked to arrhythmia and cardiomyopathy syndromes, the role of missense variants (mvs) remains unclear.
View Article and Find Full Text PDFTargeting the I Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants.
Circ Res
September 2024
Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macao SAR, China (L.Z., Z.Y., D.J., Y.O., H.Z., X.L., C.X., C.H., B.S., S.K.C., Z.-H.J., E.N., P.H.).
Article Synopsis
- The KCNQ1+KCNE1 potassium channel is vital for heart stress adaptation, where β-adrenergic stimulation enhances its activity via phosphorylation, essential for managing increased heart rates.
- Variants in the KCNQ1 gene can lead to long-QT syndrome type 1 (LQT1), with some mutations making patients more susceptible to serious heart risks, but the details of how phosphorylation affects channel function and cAMP sensitivity are still unclear.
- Research using techniques like patch clamp and induced pluripotent stem cells revealed key molecular features in LQT1 variants and identified a small molecule, ML277, that can restore function in high-risk mutations by targeting the phosphorylation axis of the channel.
Novel Q234K variant, identified in patients with long QT syndrome and epileptiform activity, induces both gain- and loss-of-function of slowly activating delayed rectifier potassium currents.
Front Physiol
July 2024
Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.
Introduction: KCNQ1 and KCNE1 form slowly activating delayed rectifier potassium currents (I). Loss-of-function of I by variants causes type-1 long QT syndrome (LQTS). Also, some variants are reported to cause epilepsy.
View Article and Find Full Text PDFHigh-throughput functional mapping of variants in an arrhythmia gene, KCNE1, reveals novel biology.
Genome Med
May 2024
Vanderbilt Genetics Institute, Vanderbilt University Medical Center, 1235 Medical Research Building IV, 2215B Garland Avenue, Nashville, TN, 37232, USA.
Background: KCNE1 encodes a 129-residue cardiac potassium channel (I) subunit. KCNE1 variants are associated with long QT syndrome and atrial fibrillation. However, most variants have insufficient evidence of clinical consequences and thus limited clinical utility.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!